4//SEC Filing
Elsbernd Brian 4
Accession 0001161697-25-000374
CIK 0001369568other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 5:00 PM ET
Size
5.2 KB
Accession
0001161697-25-000374
Insider Transaction Report
Form 4
Elsbernd Brian
Chief Compliance/Legal Officer
Transactions
- Sale
Common Stock, par value $0.001 per share
2025-11-12$22.70/sh+40,000$908,000→ 231,039 total
Footnotes (2)
- [F1]Shares were sold for personal reasons and not as a result of any disagreement with the Company.
- [F2]Represents a weighted average price for the shares sold. Shares were sold in a range from $22.55 to $23.00 per share.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001763511
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 5:00 PM ET
- Size
- 5.2 KB